Strand Therapeutics raises additional capital to series A financing By / On November 28, 2022 / At 8:39 pm / In Chemical world 28 Views The company pioneers logic-based mRNA circuitry for a more controlled drug delivery Post navigation Prev PostEmbracing oddities Next PostAlbert G. Horvath named new CEO of the American Chemical Society You May Also Like Chemists create chiral molecules using cobalt catalysts and a zap of electricity On March 28, 2023 | In Chemical world New Jersey sues Dow Chemical and others over 1,4-dioxane pollution On March 28, 2023 | In Chemical world Sentencing delayed again for Harvard’s former chemistry head On March 28, 2023 | In Chemical world